QT Imaging Holdings Secures $10.1M to Revolutionize 3D Breast Imaging and Transform Women's Health

QT Imaging Holdings is thrilled to announce a successful funding round where we raised $10,100,000 to accelerate our mission of revolutionizing medical imaging. Since our founding, the QTI team has been driven by a shared passion to uncover disruptive innovations that expand access to medical imaging, ultimately enhancing patient experience and improving health outcomes. Anchored in the belief that early detection is key to better health, our efforts have led us to develop cutting-edge, native 3D breast imaging technology that offers high resolution and generates consistently reproducible image quality regardless of operator experience or breast tissue variations. This remarkable capability is fundamental to our strategy of replacing traditional, less effective screening options. Current breast imaging practices have demonstrated notable shortcomings, contributing to unnecessary patient anxiety and excessive healthcare costs. QTI’s breakthrough scanning method is particularly effective for women with dense breasts—approximately 40% of US women—addressing a critical gap where conventional mammography falls short. Moreover, our technology offers a much-needed alternative for high-risk women under 40, whose aggressive cancers often face poor survival outcomes. Our QT Imaging Breast Acoustic CT™ Scanner is FDA-cleared for its innovative use of low-frequency soundwaves, eliminating the discomfort and risks associated with ionizing radiation, compression, and contrast dyes. The new funding will be instrumental in further refining our technology, expanding market reach, and advancing our mission to provide accessible, affordable diagnostic tools for healthcare providers. This investment not only enables us to extend our market segment but also affirms a purposeful opportunity for investors committed to transforming the future of breast health diagnostics.